Rehmann Capital Advisory Group’s MorphoSys AG American Depositary Shares MOR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
$78.2K Sell
2,847
-679
-19% -$19.5K 0.01% 512
2019
Q2
$85.1K Hold
3,526
0.01% 658
2019
Q1
$80.1K Sell
3,526
-706
-17% -$18.5K 0.01% 662
2018
Q4
$107K Sell
4,232
-997
-19% -$26.2K 0.02% 391
2018
Q3
$140K Sell
5,229
-1
-0% -$30 0.02% 495
2018
Q2
$159K Buy
+5,230
New +$144K 0.02% 436

Other funds holding MOR

Rehmann Capital Advisory Group's MOR Position: Q3 2019 in Review

Rehmann Capital Advisory Group reduced its MorphoSys AG American Depositary Shares (MOR) stake by 19% in Q3 2019, selling an estimated $19.5K and leaving 2,847 shares worth $78.2K. The position accounts for 0.01% of the portfolio, ranked #512.

Rehmann Capital Advisory Group first reported a position in MOR in Q2 2018 and has held it in 6 quarters since. The position peaked at $159K in Q2 2018. 34 funds tracked by Wall St. Rank hold MOR as of Q3 2019.

  • Rehmann Capital Advisory Group held 2,847 shares of MorphoSys AG American Depositary Shares worth $78.2K as of Q3 2019.
  • Rehmann Capital Advisory Group sold 679 MorphoSys AG American Depositary Shares shares in Q3 2019, an estimated $19.5K.
  • MorphoSys AG American Depositary Shares made up 0.01% of Rehmann Capital Advisory Group's portfolio in Q3 2019, its #512 holding.
  • Rehmann Capital Advisory Group first reported a position in MorphoSys AG American Depositary Shares in Q2 2018 and has held it in 6 quarters since.
  • Rehmann Capital Advisory Group's MorphoSys AG American Depositary Shares position peaked at $159K in Q2 2018.
  • 34 funds tracked by Wall St. Rank held MorphoSys AG American Depositary Shares as of Q3 2019.

Based on Rehmann Capital Advisory Group's 13F filing for Q3 2019, filed 2 Jan 2020.